Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › NK1 antagonists

NK1 antagonists

US Patent 7122677 · Granted Oct 17, 2006

Estimated economic value: $46,357,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Factor XI activation inhibitors2025
Prevention and treatment of organ injuries2025
Treatment and prevention of nephrotoxin-induced kidney injuries2025
Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells2025
Multicyclic compounds2024
Tetrahydroquinazoline derivatives as selective cytotoxic agents2023
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors2022
Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones2022
L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs2021
Antidiabetic bicyclic compounds2021
Antidiabetic spirochroman compounds2021